Johnson & Johnson (JNJ)

147.21
2.00 1.40
NYSE
Prev Close 145.21
Open 145.32
Day Low/High 145.26 / 147.14
52 Wk Low/High 109.16 / 157.00
Volume 3.40M
Exchange NYSE
Shares Outstanding 2634.59B
Market Cap 375.09B
P/E Ratio 22.21
Div & Yield N.A. (N.A)
Jim Cramer on Why Johnson & Johnson Returned to Actelion Talks

Jim Cramer on Why Johnson & Johnson Returned to Actelion Talks

Jim Cramer wonders whether someone at Johnson & Johnson is now willing to pay more for Actelion, or if there was more give from the other side.

Dow Goes Down, Boeing Cuts Costs and Actelion Talks Transition

Dow Goes Down, Boeing Cuts Costs and Actelion Talks Transition

This is what you need to know before the opening bell on Thursday.

Good Time to Sell Russell 2000 Puts

Good Time to Sell Russell 2000 Puts

The Fed seems to have aligned itself with the new emerging themes of financials and small-caps.

J&J Is Being Disciplined by Abandoning Merger Talks With Actelion, Jim Cramer Says

J&J Is Being Disciplined by Abandoning Merger Talks With Actelion, Jim Cramer Says

Jim Cramer comments on Johnson & Johnson's move to abandon merger talks with Actelion.

Takeaways and Observations

The markets moved lower from the "get go," though about the time Sixty Minutes was on last evening the S&P 500 futures were up 10 handles. (Futures closed down 2.5 handles)   Perhaps this is the start of a well due correction. Apropos, here is the q...

This Isn't a Bearish Pause in the Market

This Isn't a Bearish Pause in the Market

It's simply a little consolidation after a huge run. But could it develop?

Beware the Fear of Missing Out (FOMO)

Beware the Fear of Missing Out (FOMO)

There's a striking lack of volatility, and that's a flashing red warning signal.

Cramer: Effect of News on These Companies Is Positively Stunning

Cramer: Effect of News on These Companies Is Positively Stunning

But who are these buyers? Where are the sellers?

Jim Cramer Comments on J&J's Potential Deal With Actelion

Jim Cramer Comments on J&J's Potential Deal With Actelion

Jim Cramer is watching Johnson & Johnson, which may buy a Swiss drugmaker. Cramer says it's important to see how the deal is structured.

Have Traders in Johnson & Johnson Recently Turned Bullish?

Have Traders in Johnson & Johnson Recently Turned Bullish?

This stock needs more aggressive buying before it is an outright long.

Johnson & Johnson downgraded at Barclays

My Takeaways and Observations (3:30 p.m. Edition)

It may be time to embrace the contrary.    First issue (!!): The Palm Beach Chronicles.   My weekly (brief) technical review of the markets -- cooling off ahead?    BTIG's Stockton is bullish and so, as I have expressed, are most others!   Campbell ...

No More Tears: How to Play a Likely Johnson & Johnson Rally

No More Tears: How to Play a Likely Johnson & Johnson Rally

Technical support and statistical evidence suggest the stock will rebound.

The Good, the Bad and the Ugly (2:30 PM Edition)

"If you work for a living, why the hell do you kill yourself working?" -- Tuco the Ugly "The Good, the Bad and the Ugly" I did only a small amount of trading today (and added to short exposure), and there will be no "Takeaways" today (it's family ti...

Jim Cramer Salutes U.S. Veterans and the Businesses Who Support Them

Jim Cramer Salutes U.S. Veterans and the Businesses Who Support Them

Jim Cramer takes a moment to honor American veterans, and the companies who are working to support them.

Cramer: Health Care Stocks and Banks Could Be Trump Winners

Cramer: Health Care Stocks and Banks Could Be Trump Winners

But don't buy blindly. There are too many companies that can be retaliated against.

My Takeaways and Observations

"Dougie, take what Mr. Market gives you." -- Grandma Koufax And I did, Grandma Koufax.   A consecutive nine-day market drop was snapped as we regained most that was lost in that period.   Today was a great day. (Boy, would I like to annualize the pe...

Cramer: Let's Look Beyond the Ballot Box

Cramer: Let's Look Beyond the Ballot Box

After the election passes we are going to talk about companies again -- and these have done well.

Cramer: Don't Just Stand There Like Bambi; Sell Some

Cramer: Don't Just Stand There Like Bambi; Sell Some

Stocks in the health care sector seem to have no underpinnings whatsoever.

Cramer: Credibility Is a Precious Market Commodity

Cramer: Credibility Is a Precious Market Commodity

And if it's lost, good luck getting it back.

What's Valeant Worth Without Salix?

What's Valeant Worth Without Salix?

The debt-laden drugmaker needs to shore up cash, but a Salix sale might be too rash a move.

Cramer: With the Election Coming, Valeant's Problem Is Increasing

Cramer: With the Election Coming, Valeant's Problem Is Increasing

We have to ask: where is the cash flow to pay off the debt, if any important prices are rolled back?

Technical Picture Remains Mixed

Since mid- July there have been numerous negative divergences. One clear example is the chart below of new highs. During this three-and-a-half month period the S&P 500 has traded in a range above 2125 (the post-Brexit breakout). Downside attempts li...

Dependable Johnson & Johnson Needs a Band-Aid

Dependable Johnson & Johnson Needs a Band-Aid

Charts suggest that JNJ has further downside risk.

Cramer: What a Democratic Sweep Would Mean for Stocks

Cramer: What a Democratic Sweep Would Mean for Stocks

For starters, trouble for banks, drugs, energy and M&A.

Jim Cramer Reflects on the Anniversary of the Black Monday Market Crash

Jim Cramer Reflects on the Anniversary of the Black Monday Market Crash

Jim Cramer reflects on a dramatic day of selling on Wall Street that forever changed the industry.

The Good, the Bad and the Ugly

"I've never seen so many men wasted so badly." -- Blondie in The Good, the Bad and the Ugly." And now it's time to run down "The Good, the Bad and the Ugly" ...   The Good The market was up from the get-go. (T)FANG is the world's fair. High beta was...

Midday Musings From Sir Arthur Cashin

Back at morning highs and facing mild resistance at S&P 500 Index 2145/2149. WTI above $50 seems to put a bid under stocks, below $50 not so much. Stocks here and across the pond helped by rumors that sovereign funds may buy more equities. Volume a ...

Midday Report: UnitedHealth Tops Third Quarter; Netflix Drives Nasdaq Higher

Midday Report: UnitedHealth Tops Third Quarter; Netflix Drives Nasdaq Higher

U.S. stocks held higher as a series of positive earnings reports filtered in on Tuesday. Netflix boosted the Nasdaq, while Goldman Sachs pushed the Dow Jones Industrial Average higher.

Markets Await Goldman Sachs and Yahoo! Earnings on Tuesday

Markets Await Goldman Sachs and Yahoo! Earnings on Tuesday

On Tuesday, October 18, Goldman Sachs (GS) and Yahoo! (YHOO) release quarterly results.